These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 28086777

  • 1. Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea).
    Berzosa P, Esteban-Cantos A, García L, González V, Navarro M, Fernández T, Romay-Barja M, Herrador Z, Rubio JM, Ncogo P, Santana-Morales M, Valladares B, Riloha M, Benito A.
    Malar J; 2017 Jan 13; 16(1):28. PubMed ID: 28086777
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.
    Wurtz N, Fall B, Pascual A, Diawara S, Sow K, Baret E, Diatta B, Fall KB, Mbaye PS, Fall F, Diémé Y, Rogier C, Bercion R, Briolant S, Wade B, Pradines B.
    Malar J; 2012 Jun 13; 11():197. PubMed ID: 22694921
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
    Ghanchi NK, Ursing J, Beg MA, Veiga MI, Jafri S, Mårtensson A.
    Malar J; 2011 Jan 28; 10():18. PubMed ID: 21272384
    [Abstract] [Full Text] [Related]

  • 4. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F, Nsobya SL, Tukwasibwe S, Hakizimana E, Mutesa L, Mens PF, Grobusch MP, van Vugt M, Kumar N.
    Acta Trop; 2016 Dec 28; 164():329-336. PubMed ID: 27647575
    [Abstract] [Full Text] [Related]

  • 5. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
    Kaingona-Daniel EP, Gomes LR, Gama BE, Almeida-de-Oliveira NK, Fortes F, Ménard D, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F.
    Malar J; 2016 Jun 07; 15():309. PubMed ID: 27267365
    [Abstract] [Full Text] [Related]

  • 6. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
    Grais RF, Laminou IM, Woi-Messe L, Makarimi R, Bouriema SH, Langendorf C, Amambua-Ngwa A, D'Alessandro U, Guérin PJ, Fandeur T, Sibley CH.
    Malar J; 2018 Feb 27; 17(1):98. PubMed ID: 29486766
    [Abstract] [Full Text] [Related]

  • 7. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
    Jiang T, Chen J, Fu H, Wu K, Yao Y, Eyi JUM, Matesa RA, Obono MMO, Du W, Tan H, Lin M, Li J.
    Malar J; 2019 Mar 26; 18(1):101. PubMed ID: 30914041
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of molecular markers of sulfadoxine-pyrimethamine and artemisinin resistance in Plasmodium falciparum from Pakistan.
    Yaqoob A, Khattak AA, Nadeem MF, Fatima H, Mbambo G, Ouattara A, Adams M, Zeeshan N, Takala-Harrison S.
    Malar J; 2018 Dec 17; 17(1):471. PubMed ID: 30558587
    [Abstract] [Full Text] [Related]

  • 9. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
    Alareqi LMQ, Mahdy MAK, Lau YL, Fong MY, Abdul-Ghani R, Mahmud R.
    Acta Trop; 2016 Oct 17; 162():174-179. PubMed ID: 27343362
    [Abstract] [Full Text] [Related]

  • 10. Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study.
    Fall B, Pascual A, Sarr FD, Wurtz N, Richard V, Baret E, Diémé Y, Briolant S, Bercion R, Wade B, Tall A, Pradines B.
    Malar J; 2013 Mar 20; 12():107. PubMed ID: 23510258
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Plasmodium falciparum genes associated with drug resistance in Hodh Elgharbi, a malaria hotspot near Malian-Mauritanian border.
    Ould Ahmedou Salem MS, Mint Lekweiry K, Bouchiba H, Pascual A, Pradines B, Ould Mohamed Salem Boukhary A, Briolant S, Basco LK, Bogreau H.
    Malar J; 2017 Apr 05; 16(1):140. PubMed ID: 28381273
    [Abstract] [Full Text] [Related]

  • 12. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
    Bamaga OA, Mahdy MA, Lim YA.
    Malar J; 2015 Dec 22; 14():516. PubMed ID: 26693691
    [Abstract] [Full Text] [Related]

  • 13. Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India.
    Kar NP, Chauhan K, Nanda N, Kumar A, Carlton JM, Das A.
    Infect Genet Evol; 2016 Jul 22; 41():47-55. PubMed ID: 26988711
    [Abstract] [Full Text] [Related]

  • 14. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
    Enosse S, Magnussen P, Abacassamo F, Gómez-Olivé X, Rønn AM, Thompson R, Alifrangis M.
    Malar J; 2008 Jul 01; 7():115. PubMed ID: 18590577
    [Abstract] [Full Text] [Related]

  • 15. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
    Matondo SI, Temba GS, Kavishe AA, Kauki JS, Kalinga A, van Zwetselaar M, Reyburn H, Kavishe RA.
    Malar J; 2014 Apr 21; 13():152. PubMed ID: 24751352
    [Abstract] [Full Text] [Related]

  • 16. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
    Sitali L, Mwenda MC, Miller JM, Bridges DJ, Hawela MB, Hamainza B, Mudenda-Chilufya M, Chizema-Kawesha E, Daniels RF, Eisele TP, Nerland AH, Chipeta J, Lindtjorn B.
    Acta Trop; 2020 Dec 21; 212():105704. PubMed ID: 33002448
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.
    Figueiredo P, Benchimol C, Lopes D, Bernardino L, do Rosário VE, Varandas L, Nogueira F.
    Malar J; 2008 Nov 17; 7():236. PubMed ID: 19014684
    [Abstract] [Full Text] [Related]

  • 18. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM, Al-Mekhlafi HM, Atroosh WM, Ghzwani AH, Zain KA, Abdulhaq AA, Ghailan KY, Anwar AA, Eisa ZM.
    Malar J; 2020 Dec 02; 19(1):446. PubMed ID: 33267841
    [Abstract] [Full Text] [Related]

  • 19. Molecular Evidence for Plasmodium falciparum Resistance to Sulfadoxine-Pyrimethamine but Absence of K13 Mutations in Mangaluru, Southwestern India.
    Wedam J, Tacoli C, Gai PP, Siegert K, Kulkarni SS, Rasalkar R, Boloor A, Jain A, Mahabala C, Baliga S, Shenoy D, Devi R, Gai P, Mockenhaupt FP.
    Am J Trop Med Hyg; 2018 Dec 02; 99(6):1508-1510. PubMed ID: 30398146
    [Abstract] [Full Text] [Related]

  • 20. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
    Pathak A, Mårtensson A, Gawariker S, Sharma A, Diwan V, Purohit M, Ursing J.
    Malar J; 2020 Aug 14; 19(1):290. PubMed ID: 32795288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.